Onyx Pharma Releases Promising Multiple Myeloma Study Results

Posted On Sep 16 2016 by

#onyx pharma # Onyx Pharma Releases ‘Promising’ Multiple Myeloma Study Results Jul 26th 2010 9:00AM Onyx Pharmaceuticals (ONXX ) announced what it called “promising results” from a mid-stage study of its experimental drug carfilzomib in patients with relapsed and refractory multiple myeloma. ONXX shares soared 12% in recent premarket activity. Patients in the trial had been previously treated, but stopped responding to standard treatments. But nearly a quarter (24%) of the patients responded to carfilzomib for a median duration of 7.4 months. While this may not sound like a big advancement, such patients with the blood cancer usually respond to …


Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout

Posted On Sep 16 2016 by

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …


TransTech Pharma, Inc

Posted On Sep 16 2016 by

#transtech pharma # High Point, North Carolina (January 25, 2008) High Point, NC and Bagsvaerd, Denmark – January 25, 2008 – TransTech Pharma, Inc. and Novo Nordisk A/S announced today that TransTech has acquired all rights from Novo Nordisk to a portfolio of drug candidates being developed to treat metabolic disorders. This portfolio is comprised of three distinct therapeutic approaches to such treatment: H3 receptor antagonists, PPARd agonists, and 11βHSD1 inhibitors. After determining in January 2007 to focus all Novo Nordisk research and development resources on the company’s growing pipeline of protein-based pharmaceuticals, the company divested all existing preclinical and …


Amgen to Buy Onyx for $10

Posted On Sep 16 2016 by

#onyx pharma # Amgen to Buy Onyx for $10.4 Billion to Gain Cancer Drug Amgen Inc. agreed to buy Onyx Pharmaceuticals Inc. in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Amgen will pay $125 a share for Onyx’s outstanding stock, the companies said in a statement yesterday. Net of estimated Onyx cash, the deal is worth $9.7 billion. Onyx’s Kyprolis, approved last year for a rare blood cancer, may spur more than $3 billion in revenue by 2021, according to analyst estimates compiled by Bloomberg. …


How to Get a Job in Pharmaceutical Sales

Posted On Sep 15 2016 by

#pharmaceutical rep # How to get a job in pharmaceutical sales Does a job with a good salary, a company car, a flexible schedule, generous bonuses and no boss breathing down your neck sound like a dream come true? It s a reality for pharmaceutical company representatives. But the work isn t pure glamour. It s also intense, highly competitive and sometimes frustrating. Insiders say it s difficult to get your foot in the door with a drug company, and that it s challenging to excel once you ve landed that first sales job. Do you have what it takes …


Global Pharmaceutical Industry – Statistics – Facts

Posted On Sep 15 2016 by

#pharmaceutical industries # Global Pharmaceutical Industry Global Pharmaceutical Industry – Statistics Facts Statistics and facts about the pharmaceutical industry worldwide The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. The total level of pharmaceutical revenue worldwide had reached nearly one trillion U.S. dollars. North America is responsible for the largest portion, generating more than 40 percent of these revenues. This is mostly due to the leading role of the U.S. pharmaceutical industry. But as in many other industries, the Chinese pharmaceutical sector shows the highest growth …


Elite Pharma -Services

Posted On Sep 15 2016 by

#elite pharma # As well as stocking a full range of Generics and PIs, we also stock a selection of Nutritional Drinks, Dressings, Fridge lines and OTCs. Unlike other Wholesalers we list our generics by brand/livery. This enables the pharmacist to provide brand continuity as well as cater for specific customer needs. We also list our short dated products separately at special prices. All price lists and invoices show the current UK trade or Drug Tariff prices as well as the discount. This makes it easy to see your savings. Orders can be placed by phone, fax or email. As …


Elite Pharma Steroids for sale

Posted On Sep 15 2016 by

#elite pharma # Elite Pharma Steroids Buy Elite Pharma Steroids Payment Delivery Your Elite Pharma Steroids from Europe to the whole world Your purchased Elite Pharma products you can conveniently pay with following payment methods with us: PayPal Credit card Bank Transfer Skrill If the order is large enough to not fit in a shipment, we use several packages. No matter how big is your order, we assure you always have the same discretion. Shipping is always directly from Europe. We only sell genuine Elite Pharma the original manufacturer. We promise you good customer service and support to each contract. …


Bayer Schering Pharma – Mirena Healthcare Professional information

Posted On Sep 15 2016 by

#bayer schering pharma # Bayer HealthCare Pharmaceuticals A History of Innovation in Birth Control Few advances have given women greater power over their lives than the Pill. When many people hear the name Bayer. they think of aspirin. And, in fact, Bayer s introduction of aspirin in 1899 was a major innovation. What many people don t realize is that Bayer HealthCare Pharmaceuticals (formerly Schering AG) is also the world s leading maker of hormonal contraceptives for women. What s more, the company has a long history of innovation in birth control stretching back almost to the introduction of the …


Pharmaceuticals – Bayer Australia and New Zealand

Posted On Sep 15 2016 by

#bayer schering pharma # Pharmaceuticals Bayer’s Pharmaceuticals division is a significant player in the pharmaceutical industry, globally and here in Australia and New Zealand. The product portfolio lies across major business units of Women s Healthcare, General Medicine, Specialty Medicine and Diagnostic Imaging. Using new ideas, Pharmaceuticals aims to make a contribution to medical progress and strives to improve the quality of life. For further information about Pharmaceuticals visit pharma.bayer.com/ This page contains approved Product Information (PI) and Consumer Medicine Information (CMI) for Pharmaceuticals products in Australia. Product Information is intended to assist healthcare professionals make decisions about treatment options …